The hidden crisis in our hospitals: How tiny particles could save thousands of lives
Uncover the rising threat of hospital-acquired infections and how the EVQ-218 metamaterial transforms medical devices to combat antimicrobial resistance. Explore safer catheters, reduced costs, and potential life-saving innovations in healthcare.
Silver lining: A major advance in the fight against antibiotic-resistant lung infections
Discover how the EVOQ Bio EVQ-218 metamaterial revolutionizes treatment for antibiotic-resistant lung infections in cystic fibrosis and beyond. Learn about its non-ionic design, preclinical success, and path to clinical trials for safer, more effective antimicrobial therapy.
What if medical devices could prevent infections on their own?
EVQ-218 integrates into medical devices to address healthcare-associated infections. In laboratory testing, the metamaterial demonstrated greater than 4-log reduction against leading HAI pathogens without compromising device performance.
Seven benefits of non-ionic metamaterials for sustainable product reinvention
Non-ionic metamaterials drive sustainable innovation by eliminating ions and enhancing durability. The EVOQ platform technology offers benefits like scalable processes saving in costs and precision for new designs. A textile brand scaled antimicrobial fabrics, aligning with environmental goals. With high stability, EVOQ empowers industries to reinvent products reliably, reducing regulatory risks and supporting long-term sustainability across applications
How EVOQ platform technology scales metamaterials for cost-effective product innovation
Industries face escalating costs when scaling materials for new products. EVOQ platform technology addresses this with EVQ-218, offering scalable processes that reduce expenses and ensure precision. Tests have shown stability, enabling innovators to create new devices or enhance textiles efficiently. This empowers executives to overcome barriers and invest in reliable, high-volume solutions.
The escalating antibiotic resistance crisis: Warnings from experts and emerging metamaterial innovations
Antimicrobial resistance is outpacing medical advances, turning routine infections deadly, as warned by experts. Explore the crisis through WHO insights and discover how EVOQ platform technology, like EVQ-218, offer innovative, stable solutions to support antimicrobial strategies without inducing resistance.
Reflections on One Health Day highlight the potential of the EVOQ platform. Supported by peer-reviewed publications and preclinical data across 64+ isolates, the technology represents a structural approach to antimicrobial performance.
Transforming batteries with metamaterial for safer, longer life, and better performance at minimal cost
EVŌQ Nano introduces gold metamaterials that revolutionize lead acid battery performance, opening doors to broader energy sector applications. This innovation boosts energy density, improves charge acceptance, and significantly extends battery life...
William NiedermeyerFounder & Chief Technical Officer
Silver reimagined for a scientific advancement could transform healthcare and beyond
Discover how the EVOQ EVQ-218 metamaterial revolutionizes silver antimicrobial properties, overcoming traditional limitations to combat resistance in healthcare, devices, textiles, and energy. Explore this stable, non-ionic innovation for safer, sustainable solutions.
William NiedermeyerFounder & Chief Technical Officer
How our partnership with Tony Robbins is fueling our mission to combat antimicrobial resistance
EVOQ partners with Tony Robbins to advance EVQ-218, a metamaterial fighting antimicrobial resistance. His investment accelerates our therapeutics, medical devices, and textiles innovations for global health.
The beginner’s guide to stable metamaterials: Empowering innovation across industries
Metamaterials hold promise, but agglomeration hinders progress. EVOQ platform technology solves this with EVQ-218, delivering stable, non-ionic solutions for consistent nanoscale precision. This guide covers requirements like durability and safety, with applications in healthcare reducing infections from pathogens like staphylococcus aureus. A research team achieved 99.9% stability in coatings, attracting investment. EVOQ differentiates from silver-based competitors by eliminating residue risks, empowering researchers to bridge lab discoveries to market-ready innovations across sectors.
World AMR Awareness Week: Facing the hidden threat of antimicrobial resistance
Antimicrobial resistance already claims 1.27 million lives yearly and could reach 10 million by 2050. For 23-year-old Tessa living with cystic fibrosis, recurring resistant infections like Pseudomonas and MRSA are a constant fear. The EVOQ breakthrough metamaterial technology offers new hope: killing pathogens physically with no resistance detected under serial passage conditions tested, potentially transforming catheters, medical devices, and everyday infection prevention.
Biofilms are the real test: Why many antimicrobial surface claims fall short in the real world
Biofilms are the real test of antimicrobial performance — and most surface treatments aren't designed to pass it. In studies conducted at Seattle Children's Research Institute using a clinically validated biofilm assay, EVQ-218 maintained antimicrobial activity against established bacterial biofilms across multidrug-resistant and aminoglycoside-resistant strains of P. aeruginosa and S. aureus. Biofilm inhibitory concentrations remained just 4–8× above planktonic MICs — compared to at least 50–100× for anti-pseudomonal β-lactams under equivalent conditions in the same study. That narrow activity step, evaluated against clinically relevant strains in the same laboratory using the same methodology, reflects a material designed from formation to engage bacteria before biofilms become established. Performance isn't formulated. It's engineered.
Beyond the prescription: Solving AMR at the source
Antimicrobial resistance is often framed as a biological challenge, but it is fundamentally a problem of material design. As traditional chemical formulations reach their limits, the solution lies upstream: engineered metamaterials that define performance through physical architecture, not depleting additives.
How metamaterials are changing the fight against antibiotic resistance
For centuries, silver has been revered for its antimicrobial properties. From ancient civilizations using silver vessels to purify water. Generations have long recognized silver's protective powers. Yet despite this rich history, modern medicine has struggled to harness silver's full potential — until now.
The history of silver in healthcare: From ancient remedies to modern metamaterial innovations
Explore silver's evolution in medicine, from 19th-century antiseptics to modern metamaterial solutions like EVQ-218. Discover how EVOQ technology enhances safety, combats resistance, and promotes sustainability in wound care, devices, and beyond.
How metamaterial science is changing the fight against antibiotic resistance
Learn how EVQ-218, a metamaterial from EVOQ, combats antibiotic resistance by disrupting bacterial metabolism without triggering mutations. Explore applications in lung infections, medical devices, textiles, and public health for safer, sustainable solutions.
